肝脏 ›› 2016, Vol. 21 ›› Issue (2): 107-110.

• 论著 • 上一篇    下一篇

KPNA2基因沉默对人肝癌细胞株SMMC7721和Bel7404增殖和侵袭能力的影响

王涛, 马思聪, 戚星星, 汤晓寅, 崔丹, 王智, 池嘉昌, 李萍, 翟博   

  1. 200127 上海交通大学医学院附属仁济医院肿瘤介入科
  • 收稿日期:2015-09-15 出版日期:2016-02-29 发布日期:2020-06-28
  • 通讯作者: 翟博,Email:zhaiboshi@sina.com
  • 基金资助:
    本项课题受国家自然科学基金(青年项目)资助(81201678)

The impacts of KPNA2 gene silencing on the proliferation and invasion of human hepatocarcinoma cell lines SMMC7721 and Bel7404

WANG Tao, MA Si-cong, QI Xing-xing, TANG Xiao-yin, CUI Dan, WANG Zhi, CHI Jia-chang, LI Ping, ZHAI Bo   

  1. Department ofInterventional Oncology, Renji Hospital, School of Medicine, Shanghai JiaotongUniversity, Shanghai, 200127, China
  • Received:2015-09-15 Online:2016-02-29 Published:2020-06-28
  • Contact: ZHAI Bo, Email: zhaiboshi@sina.com

摘要: 目的 观察核转运蛋白基因α2(Karyopherin α-2,KPNA2)基因沉默对人肝癌细胞株SMMC7721和Bel7404增殖以及侵袭能力的影响。方法 将KPNA2 siRNA干扰质粒用LipofectaminTM 2000方法瞬时转染人肝癌细胞株SMMC7721和Bel7404,转染后48 h应用蛋白质印迹法检测转染细胞中KPNA2蛋白表达。采用MTT法检测基因沉默细胞增殖能力,采用Transwell法检测基因沉默细胞侵袭能力。结果 SMMC7721细胞株对照组mRNA为1.02±0.13,高于siRNA转染组的0.37±0.07(t=10.78,P<0.01);肝癌Bel7404细胞株对照组mRNA为1.05±0.17,高于siRNA转染组的0.36±0.06 (t=9.38,P<0.01)。肝癌SMMC7721细胞株对照组蛋白定量值为0.96±0.10,高于转染组的0.42±0.05(t=11.83,P<0.01);肝癌Bel7404细胞株对照组蛋白定量值为0.93±0.09,高于转染组的0.48±0.06(t=10.19,P<0.01)。SMMC7721和Bel7404细胞株在24、48和72 h时对照组增殖能力高于转染组,且差异有统计学意义(P<0.05)。SMMC7721细胞株对照组侵袭能力值为126.20±21.61,高于siRNA转染组的51.13±10.2 (t=7.68,P<0.01);肝癌Bel7404细胞株对照组侵袭能力值为125.124±8.04,高于siRNA转染组的55.20 ±18.54 (t=8.48,P<0.01)。结论 KPNA2基因沉默可以调节人肝癌细胞株SMMC7721和Bel7404的增殖能力和侵袭能力。

关键词: KPNA2, 肝癌细胞株, SMMC7721, Bel7404, 增殖能力, 侵袭能力

Abstract: Objective To observe the impacts of Karyopherin α-2 (KPNA2) gene silencing on proliferation and invasion of human hepatocarcinoma cell lines SMMC7721 and Bel7404. Methods Human hepatocarcinoma cell lines SMMC7721 and Bel7404 were transiently transfected with KPNA2 siRNA through adoption of LipofectaminTM 2000. Protein immunoblotting was performed to detect KPNA2 protein expression in transfected cells at 48 hours after transfection. MTT assay was carried out to assess proliferative capability of gene silencing cells, and Transwell assay was used to evaluate their invasion ability. Results Relative mRNA level of KPNA2 in control group of SMMC7721 and Bel7404 was higher than that in siRNA-transfected group (1.02±0.13 vs. 0.37±0.07, t=10.78, P<0.01; 1.05±0.1 vs. 70.36±0.06, t=9.38, P<0.01, respectively). Relative protein level in control group was higher than that in transfected group (0.96±0.10 vs. 0.42±0.05, t=11.83, P<0.01; 0.93±0.09 vs. 0.48±0.06, t=10.19, P<0.01, respectively). Proliferative capacity of control groups was stronger than that in transfected groups at 24h, 48h and 72h respectively, which revealed statistically significant differences (P<0.05). Invasive capacity in control group was more powerful than that in siRNA-transected group (126.20±21.61 vs. 51.13±10.2, t=7.68, P<0.01; 125.124±8.04 vs. 55.20 ±18.54, t=8.48, P<0.01, respectively ). Conclusion KPNA2 gene silencing could adjust the proliferative capacity and invasive ability of human hepatocarcinoma cell lines SMMC7721 and Bel7404.

Key words: KPNA2, Hepatocarcinoma cell lines, SMMC7721, Bel7404, Proliferative capacity, Invasion ability